Sensus Healthcare, Inc.
SRTS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001494891
In the last 90 days, Sensus Healthcare, Inc. insiders filed 6 open-market purchases and 0 sales; 37 institutions reported holding it in 13F filings for Q3 2026, worth $10.8M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 18, 2026
- $37.9M
- Insider buysLast 90 days, $635.6K in total
- 6
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, 0 vs. previous quarter
- 37
- 13F valueReported value at the end of Q3 2026
- $10.8M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $27.5M
- −34.3% year over year
- Net income, FY2025
- -$7.72M
- −216.1% year over year
- Free cash flow, FY2025
- $332.0K
- No comparable prior period
- Revenue, Q3 FY2026
- $6.00M
- −12.9% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $7.72M (28.1% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 222.3K
- Shares sold short
- Change
- −7.64K
- −3.3% vs. previous
- Days to cover
- 7.19
- At average daily volume
Superinvestors holding SRTS, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding SRTS at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Sensus Healthcare, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)4:27 PM ET | Nov 16 | 1 day | Sardano Joseph CCHIEF EXECUTIVE OFFICER | PPurchase | +30.0K | $2.40 | +$72.1K | +2.5%1.25M after | |
| Aug 31, 2026 (view filing)12:35 PM ET | Aug 28-31 | 3 days | Sachetta EricDirector | PPurchase | +64.8K | $3.48 | +$225.6K | +28.2%294.8K after | 2 lots |
| Aug 28, 2026 (view filing)2:29 PM ET | Aug 26-27 | 2 days | Sachetta EricDirector | PPurchase | +20.6K | $3.23 | +$66.7K | +9.9%229.9K after | 2 lots |
| Aug 25, 2026 (view filing)9:26 AM ET | Aug 24 | 1 day | Sachetta EricDirector | PPurchase | +34.7K | $3.25 | +$112.9K | +19.9%209.3K after | |
| Aug 24, 2026 (view filing)4:00 PM ET | Aug 20 | 4 days | Sardano Joseph CCHIEF EXECUTIVE OFFICER | PPurchase | +20.0K | $3.02 | +$60.5K | +1.7%1.22M after | |
| Aug 24, 2026 (view filing)3:08 PM ET | Aug 20-21 | 4 days | Sachetta EricDirector | PPurchase | +31.0K | $3.16 | +$97.8K | +21.6%174.6K after | 2 lots |
| May 12, 2026 (view filing) | May 12 | Same day | Sachetta EricDirector | PPurchase | +1.50K | $3.34 | +$5.01K | +1.1%143.6K after | |
| Feb 26, 2026 (view filing) | Feb 24 | 2 days | Sachetta EricDirector | PPurchase | +2.00K | $3.81 | +$7.62K | +1.4%142.1K after | |
| Nov 21, 2025 (view filing) | Nov 21 | Same day | Sachetta EricDirector | PPurchase | +7.00K | $3.93 | +$27.5K | +5.3%140.1K after | |
| Nov 20, 2025 (view filing) | Nov 13 | 7 days | Sachetta EricDirector | PPurchase | +2.50K | $4.50 | +$11.3K | +1.9%133.1K after | From original |
Top 10 13F holders, Q3 2026
See all 37 holdersThe largest institutional positions in Sensus Healthcare, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pacific Ridge Capital Partners, LLC | 784,339 | $2.35M | 0.41% | −5,336−0.7% | Reduced |
| Vanguard Capital Management LLC | 660,402 | $1.97M | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 301,073 | $900.4K | 0.00% | −15,048−4.8% | Reduced |
| Divisadero Street Capital Management, LP | 278,485 | $832.7K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 229,634 | $686.6K | 0.00% | −12,700−5.2% | Reduced |
| Geode Capital Management, LLC | 154,152 | $461.0K | 0.00% | 00.0% | Unchanged |
| Greenline Wealth Management LLC | 148,774 | $444.8K | 0.34% | +20,000+15.5% | Added |
| UBS Group AG | 143,146 | $428.0K | 0.00% | −9,427−6.2% | Reduced |
| North Star Investment Management Corp. | 125,586 | $375.5K | 0.02% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 101,646 | $303.9K | 0.00% | +1,236+1.2% | Added |
Holders of 5% or more of SRTS
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Sensus Healthcare, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Solot Edwin Lee | 13G/A | 7.60%1.25M shares | – | Sep 10, 20215 filings | Feb 7, 2025 | SEC |
| Sardano Joseph C | 13G/A | 7.10%1.18M shares | – | May 22, 20251 filing | May 22, 2025 | SEC |